Jérôme Lejeune
Jérôme Jean Louis Marie Lejeune (13 June 1926 – 3 April 1994) was a French pediatrician and geneticist renowned for his discovery of the link between chromosomal abnormalities and Down syndrome. His work laid the foundation for modern cytogenetics and significantly advanced the understanding of genetic disorders.
Early life and education[edit]
Jérôme Lejeune was born in Montrouge, a suburb of Paris, France. He pursued his medical studies at the University of Paris, where he developed a keen interest in genetics and pediatrics. Lejeune completed his medical degree in 1951 and subsequently began his research career.
Discovery of trisomy 21[edit]
In 1958, Lejeune made a groundbreaking discovery that would change the field of genetics. He identified that Down syndrome, a condition characterized by intellectual disability and distinct physical features, was caused by an extra copy of chromosome 21, a condition now known as trisomy 21. This discovery was pivotal in establishing the role of chromosomal abnormalities in genetic disorders.
Career and contributions[edit]
Lejeune's work extended beyond his discovery of trisomy 21. He was a pioneer in the field of cytogenetics, the study of chromosomes and their relation to disease. Lejeune's research contributed to the understanding of various genetic conditions, including Cri du chat syndrome and Fragile X syndrome.
Throughout his career, Lejeune was a vocal advocate for individuals with genetic disorders. He emphasized the importance of treating patients with dignity and respect, and he was a proponent of ethical considerations in genetic research.
Personal life[edit]
Lejeune was a devout Catholic and his faith influenced his views on medical ethics. He was a strong opponent of abortion and euthanasia, advocating for the protection of life from conception to natural death. Lejeune's beliefs often brought him into conflict with prevailing scientific and social norms.
Legacy[edit]
Jérôme Lejeune's contributions to genetics have had a lasting impact on the field. His discovery of the chromosomal basis of Down syndrome paved the way for advances in prenatal diagnosis and genetic counseling. In recognition of his work, Lejeune received numerous awards and honors, including the William Allan Award from the American Society of Human Genetics.
After his death, the Jérôme Lejeune Foundation was established to continue his work in research and advocacy for individuals with genetic disorders.
Related pages[edit]
Ad. Transform your health with W8MD Weight Loss, Sleep & MedSpa

Tired of being overweight?
Special offer:
Budget GLP-1 weight loss medications
- Semaglutide starting from $29.99/week and up with insurance for visit of $59.99 and up per week self pay.
- Tirzepatide starting from $45.00/week and up (dose dependent) or $69.99/week and up self pay
✔ Same-week appointments, evenings & weekends
Learn more:
- GLP-1 weight loss clinic NYC
- W8MD's NYC medical weight loss
- W8MD Philadelphia GLP-1 shots
- Philadelphia GLP-1 injections
- Affordable GLP-1 shots NYC
- Budget GLP-1 shots
|
WikiMD Medical Encyclopedia |
Medical Disclaimer: WikiMD is for informational purposes only and is not a substitute for professional medical advice. Content may be inaccurate or outdated and should not be used for diagnosis or treatment. Always consult your healthcare provider for medical decisions. Verify information with trusted sources such as CDC.gov and NIH.gov. By using this site, you agree that WikiMD is not liable for any outcomes related to its content. See full disclaimer.
Credits:Most images are courtesy of Wikimedia commons, and templates, categories Wikipedia, licensed under CC BY SA or similar.
Translate this page: - East Asian
中文,
日本,
한국어,
South Asian
हिन्दी,
தமிழ்,
తెలుగు,
Urdu,
ಕನ್ನಡ,
Southeast Asian
Indonesian,
Vietnamese,
Thai,
မြန်မာဘာသာ,
বাংলা
European
español,
Deutsch,
français,
Greek,
português do Brasil,
polski,
română,
русский,
Nederlands,
norsk,
svenska,
suomi,
Italian
Middle Eastern & African
عربى,
Turkish,
Persian,
Hebrew,
Afrikaans,
isiZulu,
Kiswahili,
Other
Bulgarian,
Hungarian,
Czech,
Swedish,
മലയാളം,
मराठी,
ਪੰਜਾਬੀ,
ગુજરાતી,
Portuguese,
Ukrainian